Alpha Tau Medical Ltd. (DRTSW)
DRTSW Stock Price Chart
Explore Alpha Tau Medical Ltd. interactive price chart. Choose custom timeframes to analyze DRTSW price movements and trends.
DRTSW Company Profile
Discover essential business fundamentals and corporate details for Alpha Tau Medical Ltd. (DRTSW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
125.00
Website
https://www.alphatau.comCEO
Uzi Sofer
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.
DRTSW Financial Timeline
Browse a chronological timeline of Alpha Tau Medical Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Aug 2025
EPS came in at -$0.13 falling short of the estimated -$0.11 by -13.60%.
Earnings released on 19 May 2025
EPS came in at -$0.12 surpassing the estimated -$0.12 by +2.06%.
Earnings released on 31 Dec 2023
EPS came in at -$0.11 .
DRTSW Stock Performance
Access detailed DRTSW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.